Skip to main content

Table 1 The number of samples in the training, validation, and test sets

From: A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis

 

Classifier generation

Classifier evaluation

 
 

TCGA TARGET GTEx

Clinical validation samples

 
 

Training

Validation

Test − 1st

Test − 2nd

Subtotal

Leiomyosarcoma

25

6

9

9

49

Normal tissue (uterus, cervix, cervix uteri, endometrium)

92

22

0

0

114

Leiomyoma

0

0

9

8

17

Subtotal

117

28

18

17

180